Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
State health officials report falling demand but adequate supply of COVID-19 monoclonal antibodies
Summary
Arkansas health officials reported a sharp drop in monoclonal antibody utilization, described logistics favoring subcutaneous injections, and said the state has distributed nearly 60,000 doses and holds inventory to meet future surges.
State public-health officials told the Senate Public Health, Welfare and Labor Committee that demand for COVID-19 monoclonal antibody treatments has fallen sharply since the summer but the state is managing allocations and has adequate supply.
Greg Brown, director of the Office of Preparedness and Emergency Response, said three monoclonal antibody products are being allocated to the state; two are infusion-only and one is for subcutaneous injection. He reported that utilization has “dropped about 62%” since the last briefing, from roughly 2,600 doses per week to about 990 doses, and that the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
